Skip to content

Pharmacopé

Active
Private limited companyfounded 201115 yrs activeOude Vaartstraat 9, 2300 Turnhout, BelgiumKBO/BCE: BE 0834.892.064

Pharmacopé has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €203k and a net result of €11k. Equity is growing by ~33.7% per year across the filed fiscal years. Its solvency ranks better than 95% of 8091 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
91 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability75▼-25
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 52.07 against 12.95 in 2023; short-term debt: 1.9% and cash: 36% of total assets), and 1.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 15 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-06-2025, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
51 d early
2023
33 d early
2022
17 d early
2021
41 d early
2020
44 d early
2019
29 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€203k▲ 5.6%
2023 · €192k
2018: €43k 2019: €57k 2020: €80k 2021: €124k 2022: €140k 2023: €192k
2018 → 2024
Total assets
€207k▼ 0.6%
2023 · €208k
2018: €51k 2019: €98k 2020: €109k 2021: €149k 2022: €153k 2023: €208k
2018 → 2024
Net result
€11k▼ 79.5%
2023 · €53k
2018: €10k 2019: €24k 2020: €39k 2021: €59k 2022: €16k 2023: €53k
2018 → 2024
Working capital
€202k▲ 5.9%
2023 · €190k
2018: €32k 2019: €8k 2020: €45k 2021: €99k 2022: €127k 2023: €190k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€80k-€124k▲ 54.2%€140k▲ 13.2%€192k▲ 36.9%€203k▲ 5.6%
Operating result€53k-€81k▲ 50.7%€24k▼ 70.8%€75k▲ 217%€14k▼ 81.6%
Net result€39k-€59k▲ 51.1%€16k▼ 72.1%€53k▲ 222%€11k▼ 79.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25k€50k€75kOperating result 2020: €53k€53kNet result 2020: €39k€39kOperating result 2021: €81k€81kNet result 2021: €59k€59kOperating result 2022: €24k€24kNet result 2022: €16k€16kOperating result 2023: €75k€75kNet result 2023: €53k€53kOperating result 2024: €14k€14kNet result 2024: €11k€11k20202021202220232024
The operating result falls in 2024; 2024 is 82% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €207k
Fixed assets €1k▼ 25.3%
Current assets €206k▼ 0.4%
Equity and liabilities €207k
Equity €203k▲ 5.6%
Debt €4k▼ 75.2%
The debt ratio falls from 7.7% to 1.9%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€14k
2023 · €86k
Cash flow
€11k
2023 · €64k
Solvency
98.1%
2023 · 92.3%
Current ratio
52.07
2023 · 12.95
Quick ratio
52.07
2023 · 12.95
Debt / equity
0.02
2023 · 0.08
ROE
5.3%
2023 · 27.4%
ROA
5.2%
2023 · 25.3%
Interest coverage
104.26
2023 · 864.06
Debt
€4k
2023 · €16k
Debt ≤ 1 year
€4k
2023 · €16k
Income taxes
€6k
2023 · €22k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€208k€207k
Fixed assets21/28€2k€1k
Tangible fixed assets22/27€704€273
Plant, machinery and equipment23€704€273
Financial fixed assets28€1k€1k=
Current assets29/58€206k€206k
Amounts receivable within one year40/41€837€5k
Trade receivables40€303€454
Other amounts receivable41€534€4k
Current investments50/53€100k€125k
Cash at bank and in hand54/58€105k€74k
Deferred charges and accrued income490/1€692€2k
Equity and liabilities
Total equity and liabilities10/49€208k€207k
Equity10/15€192k€203k
Contributions10/11€19k€19k=
Reserves13€158k€169k
Distributable reserves133€158k€169k
Profit (loss) carried forward14€15k€16k
Amounts payable17/49€16k€4k
Amounts payable within one year42/48€16k€4k
Trade debts44€3k€60
Suppliers440/4€3k€60
Taxes, remuneration and social security45€9k€1k
Taxes450/3€9k€1k
Other amounts payable47/48€4k€3k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€431
Other operating charges640/8€2k€2k
Gross operating margin9900€88k€16k
Operating profit (loss)9901€75k€14k
Financial income75/76B-€3k
Recurring financial income75-€3k
Financial charges65/66B€100€136
Recurring financial charges65€100€136
Profit (loss) for the period before taxes9903€75k€17k
Income taxes67/77€22k€6k
Profit (loss) for the period9904€53k€11k
Profit (loss) for the period to be appropriated9905€53k€11k
Appropriation of the result
Profit (loss) to be appropriated9906€67k€26k
Profit (loss) brought forward from the previous period14P€15k€15k
Transfer to equity691/2€52k€11k
To other reserves6921€52k€11k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
10-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Liquidity quadruplescurrent ratio 52.07
Current ratio from 12.95 to 52.07; short-term debt falls from €16k to €4k.
31-12
Financial Equity above €200kEq €203k ▲5.6%
7 profitable years in a row build equity to €203k.
28-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Equity above €150kEq €192k ▲36.9%
6 profitable years in a row build equity to €192k.
14-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Liquidity doublescurrent ratio 10.83
Current ratio from 5.00 to 10.83; short-term debt falls from €25k to €13k.
20-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial Highest result since 2018net €59k ▲51.1%
Operating result €81k, net result €59k, both a record.
31-12
Financial Equity above €100kEq €124k ▲54.2%
4 profitable years in a row build equity to €124k.
17-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Liquidity doublescurrent ratio 2.57
Current ratio from 1.22 to 2.57; short-term debt falls from €36k to €29k.
02-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
06-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
28-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
09-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
08-06
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Turnhout · 1 establishment unit since 2011
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Oude Vaartstraat 92300 Turnhout
Ground area
285 m²
Building footprint
168 m²
Volume, LiDAR
1,305 m³
Parcel 13454Q0662/00A000, Flanders · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Pharmacopé
Oude Vaartstraat 9, 2300 TurnhoutManufacture of chemicals and chemical products
since 20112.198.004.360
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13454Q0662/00A000 Flanders 285 m² 1 · 168 m² 12.4 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,691 companies in sector 70100 we hold annual accounts for 3,489. 2,362 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded24-03-2011
Fiscal year end31-12
Activities, NACEBEL
70100Activities of head offices
46150Agents in the wholesale of furniture, household goods and hardware
71121Engineering and related technical consultancy, excluding land surveyors
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.